Davis, CA, United States of America

Pamela J Lein

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Epilepsy Treatment by Pamela J Lein

Introduction

Pamela J Lein is a prominent inventor based in Davis, CA (US), known for her significant contributions to the field of epilepsy treatment. With a focus on innovative therapies, she has developed groundbreaking methods to mitigate epileptic seizures. Her work has led to the issuance of 2 patents, showcasing her dedication to advancing medical science.

Latest Patents

Lein's latest patents include a method for the mitigation of epileptic seizures through combination therapy using benzodiazepines and neurosteroids. This invention provides compositions that comprise a benzodiazepine and a neurosteroid, which can be administered in subtherapeutic doses. Additionally, her work includes compositions that combine a benzodiazepine, a neurosteroid, and an NMDA blocker, aimed at effectively reducing the occurrence of seizures.

Career Highlights

Pamela J Lein is affiliated with the University of California, where she conducts her research and develops her innovative therapies. Her academic background and research experience have positioned her as a leader in her field, contributing to the understanding and treatment of epilepsy.

Collaborations

Lein has collaborated with notable colleagues, including Michael A Rogawski and Isaac N Pessah. These partnerships have enhanced her research efforts and expanded the impact of her inventions in the medical community.

Conclusion

Pamela J Lein's work exemplifies the intersection of innovation and medical research, particularly in the treatment of epilepsy. Her patents and collaborations reflect her commitment to improving patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…